These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 24565445)
21. Cardiac microphysiological devices with flexible thin-film sensors for higher-throughput drug screening. Lind JU; Yadid M; Perkins I; O'Connor BB; Eweje F; Chantre CO; Hemphill MA; Yuan H; Campbell PH; Vlassak JJ; Parker KK Lab Chip; 2017 Oct; 17(21):3692-3703. PubMed ID: 28976521 [TBL] [Abstract][Full Text] [Related]
22. Microfabricated perfusable cardiac biowire: a platform that mimics native cardiac bundle. Xiao Y; Zhang B; Liu H; Miklas JW; Gagliardi M; Pahnke A; Thavandiran N; Sun Y; Simmons C; Keller G; Radisic M Lab Chip; 2014 Mar; 14(5):869-82. PubMed ID: 24352498 [TBL] [Abstract][Full Text] [Related]
23. Assessment of Cardiotoxicity With Stem Cell-based Strategies. Stella Stoter AM; Hirt MN; Stenzig J; Weinberger F Clin Ther; 2020 Oct; 42(10):1892-1910. PubMed ID: 32938533 [TBL] [Abstract][Full Text] [Related]
24. Preclinical approaches to assess potential kinase inhibitor-induced cardiac toxicity: Past, present and future. Yang B; Papoian T J Appl Toxicol; 2018 Jun; 38(6):790-800. PubMed ID: 29369373 [TBL] [Abstract][Full Text] [Related]
25. A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications. Phan DTT; Wang X; Craver BM; Sobrino A; Zhao D; Chen JC; Lee LYN; George SC; Lee AP; Hughes CCW Lab Chip; 2017 Jan; 17(3):511-520. PubMed ID: 28092382 [TBL] [Abstract][Full Text] [Related]
26. Enhanced structural maturation of human induced pluripotent stem cell-derived cardiomyocytes under a controlled microenvironment in a microfluidic system. Kolanowski TJ; Busek M; Schubert M; Dmitrieva A; Binnewerg B; Pöche J; Fisher K; Schmieder F; Grünzner S; Hansen S; Richter A; El-Armouche A; Sonntag F; Guan K Acta Biomater; 2020 Jan; 102():273-286. PubMed ID: 31778832 [TBL] [Abstract][Full Text] [Related]
27. Modeling Cardiovascular Diseases with hiPSC-Derived Cardiomyocytes in 2D and 3D Cultures. Sacchetto C; Vitiello L; de Windt LJ; Rampazzo A; Calore M Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403456 [TBL] [Abstract][Full Text] [Related]
28. Stem cell derived in vivo-like human cardiac bodies in a microfluidic device for toxicity testing by beating frequency imaging. Bergström G; Christoffersson J; Schwanke K; Zweigerdt R; Mandenius CF Lab Chip; 2015 Aug; 15(15):3242-9. PubMed ID: 26135270 [TBL] [Abstract][Full Text] [Related]
29. A Microfluidic Bioreactor for Toxicity Testing of Stem Cell Derived 3D Cardiac Bodies. Christoffersson J; Bergström G; Schwanke K; Kempf H; Zweigerdt R; Mandenius CF Methods Mol Biol; 2016; 1502():159-68. PubMed ID: 27052611 [TBL] [Abstract][Full Text] [Related]
30. Efficient Protocols for Fabricating a Large Human Cardiac Muscle Patch from Human Induced Pluripotent Stem Cells. Gao L; Zhang JJ Methods Mol Biol; 2021; 2158():187-197. PubMed ID: 32857374 [TBL] [Abstract][Full Text] [Related]
31. Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes. Sallam K; Li Y; Sager PT; Houser SR; Wu JC Circ Res; 2015 Jun; 116(12):1989-2004. PubMed ID: 26044252 [TBL] [Abstract][Full Text] [Related]
32. Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device. van der Meer AD; Orlova VV; ten Dijke P; van den Berg A; Mummery CL Lab Chip; 2013 Sep; 13(18):3562-8. PubMed ID: 23702711 [TBL] [Abstract][Full Text] [Related]
33. Innovations in preclinical biology: ex vivo engineering of a human kidney tissue microperfusion system. Kelly EJ; Wang Z; Voellinger JL; Yeung CK; Shen DD; Thummel KE; Zheng Y; Ligresti G; Eaton DL; Muczynski KA; Duffield JS; Neumann T; Tourovskaia A; Fauver M; Kramer G; Asp E; Himmelfarb J Stem Cell Res Ther; 2013; 4 Suppl 1(Suppl 1):S17. PubMed ID: 24564863 [TBL] [Abstract][Full Text] [Related]
34. Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells. Takeda M; Miyagawa S; Fukushima S; Saito A; Ito E; Harada A; Matsuura R; Iseoka H; Sougawa N; Mochizuki-Oda N; Matsusaki M; Akashi M; Sawa Y Tissue Eng Part C Methods; 2018 Jan; 24(1):56-67. PubMed ID: 28967302 [TBL] [Abstract][Full Text] [Related]
35. Aligned nanofiber scaffolds improve functionality of cardiomyocytes differentiated from human induced pluripotent stem cell-derived cardiac progenitor cells. Ding M; Andersson H; Martinsson S; Sabirsh A; Jonebring A; Wang QD; Plowright AT; Drowley L Sci Rep; 2020 Aug; 10(1):13575. PubMed ID: 32782331 [TBL] [Abstract][Full Text] [Related]
36. The Future of Direct Cardiac Reprogramming: Any López-Muneta L; Miranda-Arrubla J; Carvajal-Vergara X Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114756 [TBL] [Abstract][Full Text] [Related]